Source: Wedgewood Wedgewood has introduced molnupiravir to its formulary, becoming the first U.S. Veterinary compounding pharmacy to offer feline-friendly formulations of the drug, which shows promise in treating Feline Infectious Peritonitis (FIP), a typically fatal disease affecting around 15,000 U.S. cats annually. Originally developed for human viral infections like COVID-19, molnupiravir has shown potential in […]
read moreWedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)
by Editor | Oct 14, 2024 | Companion Animal
